Modulation of Microglia Polarization through Silencing of NF-B p65 by Functionalized Curdlan Nanoparticle-Mediated RNAi

Tsogzolmaa Ganbold,Qingming Bao,Jargalmaa Zandan,Agula Hasi,Huricha Baigude
DOI: https://doi.org/10.1021/acsami.9b23004
IF: 9.5
2020-01-01
ACS Applied Materials & Interfaces
Abstract:Microglia polarization plays an important role in poststroke recovery. Inhibition of proinflammatory (M1) polarization and promotion of anti-inflammatory (M2) polarization of microglia are potential therapeutic strategies for inflammation reduction and neuronal recovery after stroke. Here, we evaluated the central nervous system (CNS)-targeted short interfering RNA (siRNA) delivery ability of functionalized curdlan nanoparticles (CMI) and investigated the nuclear factor-kappa B (NF-kappa B) p65 silencing efficiency of CMI-mediated siRNA in microglia, as well as the resulting neuroprotective effect of microglia polarization and neuroprotection in vitro and in vivo. The systemic delivery of NF-kappa B p65 siRNA (sip65) complexed to CMI nanoparticles in the mouse model of transient middle cerebral artery occlusion (tMCAO) resulted in the distribution of siRNA in microglia and significant silencing in NF-kappa B p65 in the peri-infarct region. Knockdown of NF-kappa B p65 resulted in M1 to M2 phenotypic transition of microglia, evidenced by the change in the expression pattern of signature cytokines as well as inducible nitric oxide synthase and CD206. Moreover, the CMI-mediated silencing of p65 increased the density of neurons and decreased pyknosis and edema in the peri-infarct region. Assessment of the neurological deficit score on the Bederson scale revealed a significantly reduced score in the mouse model of tMCAO treated with the sip65/CMI complex. Collectively, our data suggest that CMI nanoparticles are a promising CNS-targeting siRNA delivery system, and NF-kappa B p65 may he a potential therapeutic target for inflammation reduction and poststroke recovery.
What problem does this paper attempt to address?